Author

M. Kesarwani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

D. Starczynowski· 1 shared M. Azam· 1 shared M. Azhar· 1 shared T. Latif· 1 shared Z. Kincaid· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. Starczynowski

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivMar 18, 2021

Momelotinib is a highly potent inhibitor of FLT3-mutant AML

M. Azhar, Z. Kincaid, M. Kesarwani…·M. Azam

This study shows momelotinib is a potent FLT3 inhibitor effective against FLT3-mutant AML, including resistant variants, and suppresses resistance mechanisms like FLT3 ligand and cytokine signaling.

DOI 10.1182/bloodadvances.2021004611

mousehuman

𝕏 PostBluesky